WellPoint Inc (WLP)
WLP (NYSE:Health Services)
$78.52
-1.12
-1.41%
Today's Range: 78.50 - 80.00 |
WLP Avg Daily Volume: 1,875,900
| Last Update: 06/19/13 - 4:00 PM EDT |
| Volume: 1,876,528 |
| YTD Performance: 30.73%
|
| Open: $79.52 |
| Previous Close: $79.64 |
| 52 Week Range: $52.52 -
$79.79 |
| Oustanding Shares: 300,362,528 |
| Market Cap: 23,659,556,331 |
6-Month Chart
TheStreet Ratings Grade for WLP
| Buy |
Hold
|
Sell
|
| A+ |
A |
A- |
B+ |
B |
B- |
C+ |
C |
C- |
D+ |
D |
D- |
E+ |
E |
E- |
F |
Analysts Ratings
| Historical Rec |
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
| Strong Buy |
7 |
6 |
5 |
5 |
| Moderate Buy |
0 |
0 |
0 |
0 |
| Hold |
10 |
10 |
11 |
10 |
| Moderate Sell |
1 |
1 |
1 |
1 |
| Strong Sell |
0 |
0 |
0 |
0 |
| Mean Rec. |
2.28 |
2.35 |
2.47 |
2.44 |
| Latest Dividend: |
0.38 |
| Latest Dividend Yield: |
1.90% |
| Dividend Ex-Date: |
06/06/13 |
| Price Earnings Ratio: |
9.22 |
|
| Price Earnings Comparisons: |
| WLP |
Sector Avg. |
S&P 500 |
| 9.22 |
9.20 |
17.70 |
| Price Performance History (%Change): |
| 3 Mo |
1 Yr |
3 Y |
|
23.38%
|
11.63%
|
44.22%
|
|
| GROWTH |
12 Mo |
3 Yr |
CAGR |
| Revenue |
1.60 |
0.00 |
0.00 |
| Net Income |
0.30 |
0.00 |
0.00 |
| EPS |
12.80 |
-0.17 |
-0.06 |
| Earnings for WLP: |
| EBITDA |
4.38B |
| Revenue |
61.71B |
|
Average Earnings Estimates
;Qtr (09/13);FY (12/13);FY (12/14)&HEADING_LIST1=Qtr (06/12);Qtr (09/12);FY (12/12);FY (12/13)) |
|
| Average Estimate |
$2.07 |
$1.98 |
$8.01 |
$8.19 |
| Number of Analysts |
13 |
12 |
5 |
13 |
| High Estimate |
$2.27 |
$2.08 |
$8.10 |
$8.61 |
| Low Estimate |
$1.95 |
$1.90 |
$7.97 |
$7.49 |
| Prior Year |
$2.04 |
$2.09 |
$7.56 |
$8.01 |
| Growth Rate (Year over Year) |
1.58% |
-5.26% |
6.01% |
2.25% |
By
Brittany Umar
May 29, 2013 | 9:24 AM EDT
May 14, 2013 | 7:59 AM EDT
WLP was upgraded from Hold to Buy, Jefferies said. $92 price target. Buybacks will help boost growth.
Apr 25, 2013 | 8:29 AM EDT
Shares of WLP now seen reaching $74, according to Cantor Fitzgerald. Estimates also upped, given the company's new guidance. Hold ratin...
Apr 05, 2013 | 7:44 AM EDT
WLP was initiated with a Neutral rating, said UBS. The appointment of a new CEO in March at a time when the core businesses face signif...
| Feb 28, 2013 | 12:00 PM EST
Look for companies with a track record of profitability whose stocks have low P/E and price-to-book ratios and high dividend yields.
Jan 03, 2013 | 8:09 AM EST
WLP was downgraded from Buy to Hold, Deutsche Bank said. $68 price target. Industry price increases are slowing.
Jan 02, 2013 | 8:05 AM EST
WLP was downgraded from Outperform to Neutral, Credit Suisse said. $65 price target. New analyst believes the company may face increase...
Dec 12, 2012 | 7:12 AM EST
Oppenheimer Holdings Inc Healthcare Conference (Day 1 of 2) - 12/12/12 - 12/13/12 New York, NY
Nov 08, 2012 | 8:26 AM EST
Shares of WLP now seen reaching $73, Oppenheimer said. Estimates also lowered on 3Q results. Outperform rating.
Nov 08, 2012 | 8:23 AM EST
Shares of WLP now seen reaching $64, Jefferies said. Results show signs of stability. Hold rating.
